105 related articles for article (PubMed ID: 27702664)
1. Impact of R264C and R264H polymorphisms in human aromatase function.
Baravalle R; Di Nardo G; Bandino A; Barone I; Catalano S; Andò S; Gilardi G
J Steroid Biochem Mol Biol; 2017 Mar; 167():23-32. PubMed ID: 27702664
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
Parween S; DiNardo G; Baj F; Zhang C; Gilardi G; Pandey AV
J Steroid Biochem Mol Biol; 2020 Feb; 196():105507. PubMed ID: 31669572
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism on human aromatase affects protein dynamics and substrate binding: spectroscopic evidence.
Di Nardo G; Di Venere A; Zhang C; Nicolai E; Castrignanò S; Di Paola L; Gilardi G; Mei G
Biol Direct; 2021 Apr; 16(1):8. PubMed ID: 33902660
[TBL] [Abstract][Full Text] [Related]
4. Effect of sildenafil on human aromatase activity: From in vitro structural analysis to catalysis and inhibition in cells.
Baravalle R; Valetti F; Catucci G; Gambarotta G; Chiesa M; Maurelli S; Giamello E; Barone I; Catalano S; Andò S; Di Nardo G; Gilardi G
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):438-447. PubMed ID: 27616271
[TBL] [Abstract][Full Text] [Related]
5. Rapid estrogen effects on aromatase phosphorylation in breast cancer cells.
Catalano S; Barone I; Andò S
Methods Mol Biol; 2014; 1204():155-63. PubMed ID: 25182769
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells.
Bouchard MF; Taniguchi H; Viger RS
Endocrinology; 2005 Nov; 146(11):4905-16. PubMed ID: 16109788
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an elevated aspartate pK(a) in the active site of human aromatase.
Di Nardo G; Breitner M; Bandino A; Ghosh D; Jennings GK; Hackett JC; Gilardi G
J Biol Chem; 2015 Jan; 290(2):1186-96. PubMed ID: 25425647
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study.
Kao YC; Korzekwa KR; Laughton CA; Chen S
Eur J Biochem; 2001 Jan; 268(2):243-51. PubMed ID: 11168357
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
10. Leptin induces CREB-dependent aromatase activation through COX-2 expression in breast cancer cells.
Kim HG; Jin SW; Kim YA; Khanal T; Lee GH; Kim SJ; Rhee SD; Chung YC; Hwang YJ; Jeong TC; Jeong HG
Food Chem Toxicol; 2017 Aug; 106(Pt A):232-241. PubMed ID: 28571770
[TBL] [Abstract][Full Text] [Related]
11. Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells.
Barone I; Giordano C; Malivindi R; Lanzino M; Rizza P; Casaburi I; Bonofiglio D; Catalano S; Andò S
Endocrinology; 2012 Nov; 153(11):5157-66. PubMed ID: 22962253
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
13. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
14. Two natural products, trans-phytol and (22E)-ergosta-6,9,22-triene-3β,5α,8α-triol, inhibit the biosynthesis of estrogen in human ovarian granulosa cells by aromatase (CYP19).
Guo J; Yuan Y; Lu D; Du B; Xiong L; Shi J; Yang L; Liu W; Yuan X; Zhang G; Wang F
Toxicol Appl Pharmacol; 2014 Aug; 279(1):23-32. PubMed ID: 24853760
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of human placental aromatase CYP19A1.
Ghosh D; Egbuta C; Kanyo JE; Lam TT
Biochem J; 2019 Nov; 476(21):3313-3331. PubMed ID: 31652308
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation Processes Controlling Aromatase Activity in Br east Cancer: An Update.
Catalano S; Barone I; Marsico S; Bruno R; Andò S
Mini Rev Med Chem; 2016; 16(9):691-8. PubMed ID: 26996624
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase.
Hong Y; Yu B; Sherman M; Yuan YC; Zhou D; Chen S
Mol Endocrinol; 2007 Feb; 21(2):401-14. PubMed ID: 17095574
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of aromatase.
Hong Y; Li H; Yuan YC; Chen S
Ann N Y Acad Sci; 2009 Feb; 1155():112-20. PubMed ID: 19250198
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis.
Graham-Lorence S; Khalil MW; Lorence MC; Mendelson CR; Simpson ER
J Biol Chem; 1991 Jun; 266(18):11939-46. PubMed ID: 2050688
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Structural Evolution of Cytochrome P450 Aromatase.
Di Nardo G; Zhang C; Marcelli AG; Gilardi G
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
